G6PC3 and glioblastoma: G6PC3 expression was elevated in tissues of glioblastoma with higher 18F-FDG and 18F-FMISO accumulation, and also, G6PC3 elevation was related to the poor prognosis in another independent cohort as well as TCGA database, indicating that it could become a prognostic marker in glioblastomas.